As Filed Pursuant to Rule 424(b)(5)
Registration No. 333-284510
PROSPECTUS SUPPLEMENT
(To Prospectus Supplement Dated
November 4, 2025, and Prospectus Dated January 27, 2025)
CLASS A COMMON STOCK ANNEX
Class A Common Stock
We have entered into an Omnibus Sales Agreement (the “Sales Agreement”) with TD Securities (USA) LLC, Barclays Capital Inc., The
Benchmark Company, LLC, BTIG, LLC, Canaccord Genuity LLC, Cantor Fitzgerald & Co., Clear Street LLC, Compass Point Research & Trading, LLC, H.C. Wainwright & Co., LLC, Keefe, Bruyette & Woods, Inc., Maxim Group LLC, Mizuho Securities
USA LLC, Morgan Stanley & Co. LLC, Santander US Capital Markets LLC, SG Americas Securities, LLC, and TCBI Securities Inc. doing business as Texas Capital Securities (collectively, the “Agents”), dated November 4, 2025, relating to
the sale of shares of our class A common stock, par value $0.001 per share, and shares of several series of our preferred stock, par value $0.001 per share. In accordance with the terms of the Sales Agreement, under this prospectus supplement
relating to the sale of our class A common stock (the “Common Stock Annex”), we may offer and sell shares of our class A common stock having an aggregate offering price of up to $15,854,365,265.54 from time to time through one or more of
the Agents, acting as our sales agents. The shares of class A common stock offered hereunder are among the securities described in the base prospectus supplement dated November 4, 2025, that we filed with the Securities and Exchange Commission (the
“SEC”) on such date (the “base prospectus supplement”) and an accompanying prospectus dated January 27, 2025. This Common Stock Annex should be read in conjunction with that base prospectus supplement and accompanying
prospectus and the contents of that base prospectus supplement and accompanying prospectus are incorporated by reference into this Common Stock Annex.
We had previously registered the offer, issuance and sale of up to $21,000,000,000 of our class A common stock under a prospectus supplement
dated May 1, 2025. Prior to the date of this Common Stock Annex, we have sold 13,032,625 shares of class A common stock under such prior prospectus supplement for gross proceeds of $5,145,634,734.46, with shares of class A common stock with an
aggregate offering price of up to $15,854,365,265.54 remaining unsold under such offering. As of the date of this Common Stock Annex, we have terminated such prior offering of class A common stock and the sales agreement relating to such prior
offering and such unsold shares of class A common stock will no longer be offered and sold under the prior prospectus supplement. Instead, the remaining $15,854,365,265.54 of our class A common stock will be offered and sold under this Common Stock
Annex, the base prospectus supplement dated November 4, 2025 and the accompanying prospectus.
Our class A common stock is listed on The
Nasdaq Global Select Market under the trading symbol “MSTR.” On November 3, 2025, the last sale price of our class A common stock as reported on The Nasdaq Global Select Market was $264.67 per share.
Our business and an investment in our class A common stock involve significant risks. These risks are described under the caption “Risk
Factors” beginning on page SA-3 of this Common Stock Annex, under the caption “Risk Factors”, “Risk Factors Related to the ATM Offering Programs” and “Risk Factor
Updates” in the accompanying base prospectus supplement dated November 4, 2025, and prospectus and in the documents incorporated by reference into the accompanying base prospectus supplement dated November 4, 2025, and prospectus.
Neither the SEC nor any state or foreign securities commission or regulatory authority has approved or disapproved of these securities or
passed upon the adequacy or accuracy of this Common Stock Annex, the base prospectus supplement dated November 4, 2025 or the accompanying prospectus. Any representation to the contrary is a criminal offense.
|
|
|
|
|
|
|
| TD Securities |
|
Barclays |
|
The Benchmark Company |
|
BTIG |
|
|
|
|
| Canaccord Genuity |
|
Cantor |
|
Clear Street |
|
Compass Point |
|
|
|
|
| H.C. Wainwright & Co. |
|
Keefe, Bruyette & Woods
A Stifel Company |
|
Maxim Group LLC |
|
Mizuho |
|
|
|
|
| Morgan Stanley |
|
Santander |
|
SOCIETE GENERALE |
|
Texas Capital Securities |
November 4, 2025